Jpmorgan Chase & CO Alcon Inc Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Alcon Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,785,641 shares of ALC stock, worth $248 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,785,641

Previous 2,099,150 32.7%

Holding current value

$248 Million

Previous $178 Million 48.4%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$82.73 - $96.8 $56.8 Million - $66.5 Million	686,491 Added 32.7%	2,785,641 $264 Million
Q4 2024 Feb 12, 2025	SELL	$83.87 - $99.15 $83.5 Million - $98.8 Million	-996,143 Reduced 32.18%	2,099,150 $178 Million
Q3 2024 Dec 26, 2024	BUY	$88.07 - $100.79 $6.69 Million - $7.66 Million	75,986 Added 2.52%	3,095,293 $310 Million
Q3 2024 Nov 08, 2024	BUY	$88.07 - $100.79 $2.24 Million - $2.56 Million	25,400 Added 0.84%	3,044,707 $305 Million
Q2 2024 Dec 26, 2024	SELL	$77.58 - $92.26 $1.97 Million - $2.34 Million	-25,400 Reduced 0.83%	3,019,307 $269 Million
Q2 2024 Aug 12, 2024	BUY	$77.58 - $92.26 $85.3 Million - $101 Million	1,099,556 Added 57.28%	3,019,307 $269 Million
Q1 2024 Dec 26, 2024	SELL	$74.84 - $88.15 $84.2 Million - $99.2 Million	-1,124,956 Reduced 36.95%	1,919,751 $160 Million
Q1 2024 May 10, 2024	SELL	$74.84 - $88.15 $11.7 Million - $13.8 Million	-156,951 Reduced 7.56%	1,919,751 $160 Million
Q4 2023 Dec 26, 2024	SELL	$69.57 - $78.12 $67.3 Million - $75.6 Million	-968,005 Reduced 31.79%	2,076,702 $162 Million
Q4 2023 Feb 12, 2024	BUY	$69.57 - $78.12 $20.7 Million - $23.3 Million	297,734 Added 16.74%	2,076,702 $162 Million
Q3 2023 Nov 14, 2023	BUY	$76.74 - $85.2 $51 Million - $56.6 Million	664,360 Added 59.6%	1,778,968 $137 Million
Q2 2023 Aug 11, 2023	SELL	$69.16 - $82.11 $28 Million - $33.3 Million	-405,292 Reduced 26.67%	1,114,608 $91.5 Million
Q1 2023 May 11, 2023	SELL	$64.46 - $77.23 $2.7 Million - $3.24 Million	-41,953 Reduced 2.69%	1,519,900 $107 Million
Q4 2022 Feb 13, 2023	SELL	$56.51 - $71.71 $672,469 - $853,348	-11,900 Reduced 0.76%	1,561,853 $107 Million
Q3 2022 Nov 14, 2022	SELL	$56.96 - $78.09 $6.65 Million - $9.12 Million	-116,829 Reduced 6.91%	1,573,753 $91.6 Million
Q2 2022 Aug 11, 2022	SELL	$64.25 - $81.25 $42.6 Million - $53.9 Million	-663,710 Reduced 28.19%	1,690,582 $118 Million
Q1 2022 May 11, 2022	BUY	$71.65 - $87.13 $71.2 Million - $86.6 Million	993,359 Added 72.99%	2,354,292 $187 Million
Q4 2021 Feb 10, 2022	SELL	$77.91 - $88.5 $49.6 Million - $56.4 Million	-637,240 Reduced 31.89%	1,360,933 $119 Million
Q3 2021 Nov 12, 2021	BUY	$68.18 - $87.25 $136 Million - $174 Million	1,998,173 New	1,998,173 $161 Million

Others Institutions Holding ALC

# of Institutions

770

Shares Held

249M

Call Options Held

2.55M

Put Options Held

4.13M

View Full List

About ALCON INC

Ticker ALC
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 490,087,008
Market Cap $43.7B
Description
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...

More about ALC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Alcon Inc Transaction History